Today we cover a major Alzheimer's disease genetics study showing common DNA variants matter far more than thought, new data showing ectopic Cushing syndrome should be treated as a time-critical emergency, and blood…
All episodes.
47 episodes. A 10‑minute briefing on the newest peer‑reviewed studies, every single day.
A daily briefing on new medical research for busy clinicians. Today we cover a major survival win in small cell lung cancer, a fatal setback in the first human gene editing trial for Duchenne muscular dystrophy, new…
A daily briefing on new medical research for clinicians and the curious. Today we cover a newly identified bacterial toxin behind severe necrotizing enterocolitis, a global burden study on unintentional poisoning, a…
Today's briefing covers a major survival gain in small cell lung cancer, the largest Alzheimer's genetics study to date, and five year results on skipping chemotherapy in HER2 positive breast cancer. We also look at…
Today we cover a New England Journal of Medicine review on adult ADHD, real world data on RSV vaccines and antibodies, why the first solid tumor CAR-T therapy only adds a few months of survival, a new hormonal…
A chemotherapy free regimen beats standard treatment in a major leukemia trial, and a closely watched heart disease drug lowers a key risk marker without lowering heart attacks or strokes. We also cover emerging…
A daily briefing on new medical research for busy clinicians. Today we cover a stopped-early critical care trial on kidney support, a practice-changing leukemia regimen, a New England Journal of Medicine primer on…
11 min
Chemo-Free Leukemia Wins, Estrogen's Role in Drug Resistance, and Rethinking Heart Attack Triage
Today's briefing covers a chemotherapy-free regimen that outperforms standard treatment in Philadelphia-positive acute lymphoblastic leukemia, a Cell study showing estrogen drives resistance to antibody-drug…
A chemotherapy free combination beats standard treatment for adult Philadelphia positive leukemia in a major trial. New research in Nature and Cell reveals how gut bacteria and a little known gene protect arteries…
Monday's briefing covers a major review on adult attention deficit hyperactivity disorder, a practice-changing leukemia trial pairing ponatinib with blinatumomab, and a phase two trial of oral icotrokinra for…